Paper39655198
Targeted lung cancer screening in the age of immunotherapies and targeted therapies - an economic evaluation for Australia.
Roseleur J and 7 others. Lancet Reg Health West Pac, 2024. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Targeted lung cancer screening in the age of immunotherapies and targeted therapies - an economic evaluation for Australia. Papers, record 39655198. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39655198
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeted lung cancer screening in the age of immunotherapies and targeted therapies - an economic evaluation for Australia.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32786189 | The Effect of Advances in Lung-Cancer Treatment on Population Mortality. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32786189 | PubMed |
| 2 | 28376113 | Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study. | PLoS Med | 2017 | https://conductscience.org/library/papers/28376113 | PubMed |
| 3 | 33687470 | Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. | JAMA | 2021 | https://conductscience.org/library/papers/33687470 | PubMed |
| 4 | 31995683 | Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. | N Engl J Med | 2020 | https://conductscience.org/library/papers/31995683 | PubMed |
| 5 | 32866213 | Health services costs for lung cancer care in Australia: Estimates from the 45 and Up Study. | PLoS One | 2020 | https://conductscience.org/library/papers/32866213 | PubMed |
| 6 | 33687469 | Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force. | JAMA | 2021 | https://conductscience.org/library/papers/33687469 | PubMed |
| 7 | 37883107 | Risk Model-Based Lung Cancer Screening and Racial and Ethnic Disparities in the US. | JAMA Oncol | 2023 | https://conductscience.org/library/papers/37883107 | PubMed |
| 8 | 37357233 | Development and Validation of txSim: A Model of Advanced Lung Cancer Treatment in Australia. | Pharmacoeconomics | 2023 | https://conductscience.org/library/papers/37357233 | PubMed |
| 9 | 29377878 | Implementing Endobronchial Ultrasound-Guided (EBUS) for Staging and Diagnosis of Lung Cancer: A Cost Analysis. | Med Sci Monit | 2018 | https://conductscience.org/library/papers/29377878 | PubMed |
| 10 | 22882884 | Chapter 2: Birth-cohort-specific estimates of smoking behaviors for the U.S. population. | Risk Anal | 2012 | https://conductscience.org/library/papers/22882884 | PubMed |
| 11 | 36592498 | Economic impact of using risk models for eligibility selection to the International lung screening Trial. | Lung Cancer | 2023 | https://conductscience.org/library/papers/36592498 | PubMed |
| 12 | 21714641 | Reduced lung-cancer mortality with low-dose computed tomographic screening. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21714641 | PubMed |
| 13 | 36745885 | Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness Analysis. | Ann Intern Med | 2023 | https://conductscience.org/library/papers/36745885 | PubMed |
| 14 | 36323879 | Updated cost-effectiveness analysis of lung cancer screening for Australia, capturing differences in the health economic impact of NELSON and NLST outcomes. | Br J Cancer | 2023 | https://conductscience.org/library/papers/36323879 | PubMed |
| 15 | 25312998 | Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trials. | Cancer Epidemiol Biomarkers Prev | 2015 | https://conductscience.org/library/papers/25312998 | PubMed |
| 16 | 31246249 | Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers. | JAMA Oncol | 2019 | https://conductscience.org/library/papers/31246249 | PubMed |
| 17 | 32040195 | Disparities of National Lung Cancer Screening Guidelines in the US Population. | J Natl Cancer Inst | 2020 | https://conductscience.org/library/papers/32040195 | PubMed |
| 18 | 31566216 | A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies. | J Natl Cancer Inst | 2020 | https://conductscience.org/library/papers/31566216 | PubMed |
| 19 | 37792671 | Cost-effectiveness of risk-based low-dose computed tomography screening for lung cancer in Switzerland. | Int J Cancer | 2024 | https://conductscience.org/library/papers/37792671 | PubMed |
| 20 | 23425165 | Selection criteria for lung-cancer screening. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23425165 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42549076 | Use and impact of risk-based eligibility models in low-dose computed tomography lung cancer screening: a systematic review. | Public Health Rev | 2026 | https://conductscience.org/library/papers/42549076 | PubMed |
| 42487098 | Cost-Effectiveness and Budget Impact of Lung Cancer Screening: A Systematic Review. | Pharmacoeconomics | 2026 | https://conductscience.org/library/papers/42487098 | PubMed |
| 41277588 | Impact of lung cancer screening eligibility criteria on participants' characteristics and healthcare resources. | Int J Cancer | 2026 | https://conductscience.org/library/papers/41277588 | PubMed |
| 40932847 | Influence of changing patterns in lung cancer treatment and survival on the cost-effectiveness of CT screening: a modeling study. | EClinicalMedicine | 2025 | https://conductscience.org/library/papers/40932847 | PubMed |
| 40705331 | Computed Tomographic Screening Intervals for Patients at Moderate Risk of Lung Cancer. | JAMA Netw Open | 2025 | https://conductscience.org/library/papers/40705331 | PubMed |
| 40387288 | 'Every Touch Point Is an Opportunity': Tobacco Control Experts' Views on How to Implement Smoking Cessation Interventions Within an Australian Lung Cancer Screening Program. | Cancer Med | 2025 | https://conductscience.org/library/papers/40387288 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39655198
GET https://conductscience.org/api/papers/v1/39655198/references?page=2